XML 81 R94.htm IDEA: XBRL DOCUMENT v2.4.1.9

Equity Method Investments - Schedule of Equity Method Investments (Parenthetical) (Detail) In Thousands, except Share data, unless otherwise specified	12 Months Ended				0 Months Ended					0 Months Ended									0 Months Ended
	Dec. 31, 2014 USD ($)	Dec. 31, 2014 CNY	Dec. 31, 2013 CNY	Dec. 31, 2012 CNY	Oct. 27, 2014 Suzhou Chorus Medical Technologies Co., Ltd [Member] USD ($)	Oct. 27, 2014 Suzhou Chorus Medical Technologies Co., Ltd [Member] CNY	Dec. 31, 2014 Suzhou Chorus Medical Technologies Co., Ltd [Member]	Dec. 31, 2013 Suzhou Chorus Medical Technologies Co., Ltd [Member]	Dec. 17, 2012 Suzhou Chorus Medical Technologies Co., Ltd [Member] CNY	Aug. 31, 2013 JYADK [Member] CNY	Dec. 31, 2014 JYADK [Member]	Dec. 31, 2013 JYADK [Member]	Dec. 31, 2012 JYADK [Member] CNY	Dec. 31, 2011 JYADK [Member] CNY	Dec. 31, 2014 BPC [Member]	Dec. 31, 2013 BPC [Member]	Oct. 19, 2012 BPC [Member] CNY	Dec. 28, 2012 MD Anderson Cancer Center Proton Therapy Center [Member]	Mar. 03, 2014 Global Oncology [Member]	Dec. 31, 2014 Global Oncology [Member]	Mar. 03, 2014 Global Oncology [Member] USD ($)	Mar. 03, 2014 Global Oncology [Member] CNY	Dec. 28, 2012 PTC [Member] USD ($)	Dec. 28, 2012 PTC [Member] CNY	Dec. 28, 2012 PTC GP Management LLC [Member]	Dec. 28, 2012 General Partner [Member]
Schedule of Equity Method Investments [Line Items]
Voting interest acquired													6.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember	27.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember
Equity interest in equity method investment	100.00%us-gaap_EquityMethodInvestmentOwnershipPercentage	100.00%us-gaap_EquityMethodInvestmentOwnershipPercentage					36.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember	36.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember	36.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember		33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember	33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember			25.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_BeijingProtonTreatmentCenterMember	25.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_BeijingProtonTreatmentCenterMember	25.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_BeijingProtonTreatmentCenterMember	44.40%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_UniversityOfTexasMdAndersonCancerCenterMember		46.90%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember	46.90%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember	46.90%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember	44.55%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_BusinessAcquisitionAxis = ccm_ProtonTherapyCentreHoustonManagementLimitedPartnersMember	44.55%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_BusinessAcquisitionAxis = ccm_ProtonTherapyCentreHoustonManagementLimitedPartnersMember	45.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_BusinessAcquisitionAxis = ccm_ProtonTherapyCenterGpManagementLimitedLiabilityCompanyMember	1.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_BusinessAcquisitionAxis = us-gaap_GeneralPartnerMember
Number of invested shares																			340,000us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember
Purchase price of entity									2,400us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember				120us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember	540us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember			25,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_BeijingProtonTreatmentCenterMember				$ 743us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember	4,610us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / dei_LegalEntityAxis = ccm_GlobalOncologyOneIncMember	$ 32,291us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / us-gaap_BusinessAcquisitionAxis = ccm_ProtonTherapyCentreHoustonManagementLimitedPartnersMember	201,176us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet / us-gaap_BusinessAcquisitionAxis = ccm_ProtonTherapyCentreHoustonManagementLimitedPartnersMember
Investments in equity method investees	$ 1,053us-gaap_PaymentsToAcquireEquityMethodInvestments	6,534us-gaap_PaymentsToAcquireEquityMethodInvestments	2,640us-gaap_PaymentsToAcquireEquityMethodInvestments	228,696us-gaap_PaymentsToAcquireEquityMethodInvestments	$ 309us-gaap_PaymentsToAcquireEquityMethodInvestments / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember	1,920us-gaap_PaymentsToAcquireEquityMethodInvestments / dei_LegalEntityAxis = ccm_SuzhouChorusMedicalTechnologiesCoLtdMember				2,640us-gaap_PaymentsToAcquireEquityMethodInvestments / dei_LegalEntityAxis = ccm_XianJiangyuanAndikeLtdMember

X

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireEquityMethodInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration